نتائج البحث

Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey.

• Authors : Armstrong, April W.¹ (AUTHOR) ; Jayade, Sayeli² (AUTHOR); Rege, Sanika² (AUTHOR)

• Source: Dermatology & Therapy. Feb2024, Vol. 14 Issue 2, p421-439. 19p.

تفاصيل العنوان

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis.

• Authors : Armstrong, April W.¹ (AUTHOR); Park, Sang Hee² (AUTHOR); Patel, Vardhaman² (AUTHOR)

• Source: Dermatology & Therapy. Nov2023, Vol. 13 Issue 11, p2589-2603. 15p.

تفاصيل العنوان

SLC6A4 gene variants moderate associations between childhood food insecurity and adolescent mental health.

• Authors : Pilkay, S.¹ (AUTHOR) ; Nolasco, M.¹ (AUTHOR); Nunes, S.¹ (AUTHOR)

• Source: Brain & Behavior. Feb2024, Vol. 14 Issue 2, p1-8. 8p.

تفاصيل العنوان

Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment.

• Authors : Feldman SR; Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Guerin A

Subjects: Dermatitis, Atopic*/Dermatitis, Atopic*/Dermatitis, Atopic*/therapy ; Patient Preference* ; Severity of Illness Index*

• Source: The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2345739. Date of Electronic Publication: 2024 May 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Effects of anodal tDCS on electroencephalography correlates of cognitive control in mild-to-moderate traumatic brain injury.

• Authors : Mertens, Nickolas¹; Cavanagh, James²; Brandt, Emma¹

• Source: NeuroRehabilitation. 2023, Vol. 53 Issue 2, p209-220. 12p. 3 Diagrams, 1 Chart, 3 Graphs.

تفاصيل العنوان

Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial.

• Authors : Moya, Jaynier¹ (AUTHOR); Temech, Marisol² (AUTHOR); Parra, Sergio² (AUTHOR)

• Source: Open Forum Infectious Diseases. Jul2023, Vol. 10 Issue 7, p1-8. 8p.

تفاصيل العنوان

Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF©) and determination of a threshold score for moderate symptoms.

• Authors : Shields, Alan L.¹ (AUTHOR); Taylor, Fiona¹ (AUTHOR) ; Lamoureux, Roger E.¹ (AUTHOR)

• Source: Orphanet Journal of Rare Diseases. 3/25/2023, p1-11. 11p.

تفاصيل العنوان

Treatment preferences among patients with mild-to-moderate atopic dermatitis.

• Authors : Myers, Kelley¹ (AUTHOR) ; Silverberg, Jonathan I.² (AUTHOR); Parasuraman, Shreekant³ (AUTHOR)

• Source: Journal of Dermatological Treatment. 2023, Vol. 34 Issue 1, p1-10. 10p.

تفاصيل العنوان

A phase 1, open-label, randomized drug–drug interaction study of zanubrutinib with moderate or strong CYP3A inhibitors in patients with B-cell malignancies.

• Authors : Tariq, Bilal¹ (AUTHOR); Ou, Ying C.² (AUTHOR); Stern, Jennifer C.² (AUTHOR)

• Source: Leukemia & Lymphoma. Feb2023, Vol. 64 Issue 2, p329-338. 10p.

تفاصيل العنوان

Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: A phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial.

• Authors : Viscusi, Eugene R.¹ ; de Leon‐Casasola, Oscar²; Cebrecos, Jesús³

• Source: Pain Practice. Jan2023, Vol. 23 Issue 1, p8-22. 15p. 1 Diagram, 4 Charts, 3 Graphs.

تفاصيل العنوان